These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8506315)

  • 1. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system.
    Whitesell L; Geselowitz D; Chavany C; Fahmy B; Walbridge S; Alger JR; Neckers LM
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4665-9. PubMed ID: 8506315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
    Boado RJ; Kang YS; Wu D; Pardridge WM
    Drug Metab Dispos; 1995 Nov; 23(11):1297-300. PubMed ID: 8591734
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrastriatal and intraventricular injections of oligodeoxynucleotides in the rat brain: tissue penetration, intracellular distribution and c-fos antisense effects.
    Grzanna R; Dubin JR; Dent GW; Ji Z; Zhang W; Ho SP; Hartig PR
    Brain Res Mol Brain Res; 1998 Dec; 63(1):35-52. PubMed ID: 9838035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat.
    Yee F; Ericson H; Reis DJ; Wahlestedt C
    Cell Mol Neurobiol; 1994 Oct; 14(5):475-86. PubMed ID: 7621508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain.
    Ogawa S; Brown HE; Okano HJ; Pfaff DW
    Regul Pept; 1995 Oct; 59(2):143-9. PubMed ID: 8584749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo modulation of the rat cytochrome P450 1A1 by double-stranded phosphorothioate oligodeoxynucleotides.
    Tracewell W; Desjardins J; Iversen P
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):179-84. PubMed ID: 8545825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion.
    Broaddus WC; Prabhu SS; Gillies GT; Neal J; Conrad WS; Chen ZJ; Fillmore H; Young HF
    J Neurosurg; 1998 Apr; 88(4):734-42. PubMed ID: 9525721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bis-Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides are highly selectively taken up by the liver.
    Bijsterbosch MK; Manoharan M; Dorland R; Van Veghel R; Biessen EA; Van Berkel TJ
    J Pharmacol Exp Ther; 2002 Aug; 302(2):619-26. PubMed ID: 12130724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved systemic pharmacokinetics, biodistribution, and antitumor activity of CpG oligodeoxynucleotides complexed to endogenous antibodies in vivo.
    Palma E; Cho MJ
    J Control Release; 2007 Jul; 120(1-2):95-103. PubMed ID: 17509715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization.
    Yaida Y; Nowak TS
    Regul Pept; 1995 Oct; 59(2):193-9. PubMed ID: 8584754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells.
    Fisher TL; Terhorst T; Cao X; Wagner RW
    Nucleic Acids Res; 1993 Aug; 21(16):3857-65. PubMed ID: 8396239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain.
    Szklarczyk A; Kaczmarek L
    J Neurosci Methods; 1995 Aug; 60(1-2):181-7. PubMed ID: 8544478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
    Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodeoxynucleotides induce brain inflammation in rats when infused intracerebroventricularly.
    Elepfandt P; Rupprecht S; Schöning-Burkhardt B; Volk HD; Woiciechowsky C
    Neurosci Lett; 2002 Apr; 322(2):107-10. PubMed ID: 11958855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.
    Leiter JM; Agrawal S; Palese P; Zamecnik PC
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3430-4. PubMed ID: 2333292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4'-C-Trifluoromethyl modified oligodeoxynucleotides: synthesis, biochemical studies, and cellular uptake properties.
    Zhou Y; Zang C; Wang H; Li J; Cui Z; Li Q; Guo F; Yan Z; Wen X; Xi Z; Zhou C
    Org Biomol Chem; 2019 Jun; 17(22):5550-5560. PubMed ID: 31112186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oligodeoxynucleotides encapsulated in liposomes: effect of lipid composition and preparation method.
    Aliño SF; Crespo J; Tarrasón G; Blaya C; Adán J; Escrig E; Benet M; Crespo A; Peris JE; Piulats J
    Xenobiotica; 1999 Dec; 29(12):1283-91. PubMed ID: 10647913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
    Sands H; Gorey-Feret LJ; Cocuzza AJ; Hobbs FW; Chidester D; Trainor GL
    Mol Pharmacol; 1994 May; 45(5):932-43. PubMed ID: 8190109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of antisense analogues in the central nervous system.
    Szklarczyk A; Kaczmarek L
    Neurochem Int; 1997 Sep; 31(3):413-23. PubMed ID: 9246683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.